Margaret Ponto
Family · Plymouth, INNPI 1982311924
Payments from drug & device makers
Across 185 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$474
- Vanda Pharmaceuticals Inc.$361
- Otsuka America Pharmaceutical, Inc.$193
- Bayer$171
- Lilly USA, LLC$163
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,774100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,062 |
| Novo Nordisk | 15 | $474 |
| Vanda Pharmaceuticals Inc. | 12 | $361 |
| Otsuka America Pharmaceutical, Inc. | 11 | $193 |
| Bayer | 7 | $171 |
| Lilly USA, LLC | 10 | $163 |
| Boehringer Ingelheim | 9 | $141 |
| Johnson & Johnson | 3 | $134 |
| Grifols USA, LLC | 5 | $113 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $103 |
| Paratek Pharmaceuticals, Inc. | 5 | $86 |
| Amgen | 5 | $82 |
| Pfizer | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| AstraZeneca | 5 | $69 |
| Esperion Therapeutics, Inc. | 4 | $66 |
| Alkermes, Inc. | 4 | $62 |
| Antares Pharma, Inc. | 4 | $60 |
| Lundbeck LLC | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Corcept Therapeutics | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Novartis | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,774 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 33 | $45,570 |
| RybelsusSemaglutide | 19 | $45,513 |
| OzempicSemaglutide | 26 | $43,847 |
| JanuviaSitagliptin Phosphate | 17 | $20,060 |
| EliquisApixaban | 17 | $19,240 |
| MounjaroTirzepatide | 16 | $16,943 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $15,350 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $6,694 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $4,395 |
| Levothyroxine Sodium | 153 | $1,275 |
| Gabapentin | 39 | $999 |
| Simvastatin | 145 | $899 |
| Lisinopril | 135 | $845 |
| Cephalexin | 37 | $802 |
| Celecoxib | 18 | $690 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $474 | $89,36045 claims |
| Boehringer IngelheimJardiance | $141 | $45,57033 claims |
| MerckJanuvia | $14 | $20,06017 claims |
| PfizerEliquis | $81 | $19,24017 claims |
| Lilly USA, LLCMounjaro | $163 | $16,94316 claims |
| AstraZenecaSymbicort | $69 | $6,69420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.
Other family in Plymouth
- Candie BooksPlymouth$15K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.